Location History:
- Munich, DE (2017)
- Augsburg, DE (2022)
Company Filing History:
Years Active: 2017-2025
Title: Carola Steiger: Innovator in Bispecific Antibody Development
Introduction
Carola Steiger is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents is focused on a cross-species-specific PSMAxCD3 bispecific single chain antibody. This invention relates to a bispecific single chain antibody molecule that includes a first binding domain capable of binding to an epitope of the human and non-chimpanzee primate CD3 epsilon chain. The epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs. 2, 4, 6, and 8. Additionally, it features a second binding domain that binds to prostate-specific membrane antigen (PSMA). The invention also encompasses nucleic acids encoding this bispecific single chain antibody molecule, as well as vectors, host cells, and a process for its production. Furthermore, it relates to pharmaceutical compositions that include this bispecific single chain antibody molecule and its medical applications.
Career Highlights
Carola has worked with notable companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Amgen Research GmbH. Her experience in these organizations has contributed to her expertise in antibody development and research.
Collaborations
Some of her coworkers include Peter Kufer and Matthias Klinger, who have collaborated with her on various projects in the field of biotechnology.
Conclusion
Carola Steiger's innovative work in bispecific antibodies represents a significant advancement in medical science. Her contributions are expected to have a lasting impact on the development of new therapeutic options.